Gattex Kit
Product Images NDC 68875-0103

Product Visual Gallery

This gallery contains 29 technical images submitted to the FDA as part of the official labeling for Gattex (NDC 68875-0103). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Gattex 01)

Chemical structure diagram showing the amino acid sequence of teduglutide, the active ingredient in Gattex. The sequence is displayed as a series of connected labeled ovals representing individual amino acids.*

FDA Label Image

Figure 2 (Gattex 02)

A line graph comparing change in parenteral nutrition (PN) volume in liters per week over 24 weeks between two groups: Placebo and Teduglutide 0.05 mg/kg/day. The x-axis shows visit weeks (0 to 24), and the y-axis shows change in PN volume, with Teduglutide group showing a greater reduction over time compared to placebo. The number of subjects at each visit is listed below the x-axis for both groups. Error bars indicate variability around each point.*

FDA Label Image

Image (Gattex 03)

Gattex kit by Takeda Pharmaceuticals America, Inc., containing 5 mg/0.5 mL vials of teduglutide for injection. The kit includes plastic dosing syringes with needles attached (26G, 5/8 inch), prefilled syringes containing sterile water diluent, additional needles (22G, 1.5 inch) to attach to the diluent syringes, and alcohol swab pads. Components are neatly arranged in a compartmentalized box.*

FDA Label Image

Figure A (Gattex 04)

Illustration showing components of the Gattex kit, including a vial labeled Gattex, diluent syringe with white cap, needle for reconstitution, plastic dosing syringe, and alcohol swab pads, arranged on a flat surface. This kit is for the preparation and administration of Gattex (teduglutide).*

FDA Label Image

Figure B1 (Gattex 05)

An instructional illustration showing two parts of a syringe: the plunger and the barrel. The image includes a labeled needle package specifying a BD 22 gauge, 1 1/2 inch PrecisionGlide needle, indicating needle size and type.*

FDA Label Image

Figure B2 (Gattex 06)

Illustration showing hands preparing an injection device, including removing a cap and attaching parts. The image likely demonstrates steps for using the Gattex (teduglutide) 5 mg/0.5 mL kit by Takeda Pharmaceuticals America, Inc.*

FDA Label Image

Figure B3 (Gattex 07)

An instructional illustration showing a person peeling back a foil blister pack containing a single-dose container, likely part of the Gattex (teduglutide) 5 mg/0.5 mL kit by Takeda Pharmaceuticals America, Inc.*

FDA Label Image

Figure C (Gattex 08)

Black and white photo showing a person's hands holding parts of an injectable drug delivery system. The left hand holds a needle or syringe component, and the right hand holds a glass cartridge or vial. This image likely demonstrates preparation or assembly steps for administering the injectable drug Gattex (teduglutide) 5 mg/0.5 mL kit by Takeda Pharmaceuticals America, Inc.*

FDA Label Image

Figure D (Gattex 09)

Black and white photo showing two hands holding a vial and a syringe, illustrating preparation or handling of an injectable medication.*

FDA Label Image

Figure E (Gattex 10)

A black-and-white photograph showing a person manipulating a vial, likely preparing an injection by removing the vial's cap. The vial is small and labeled, consistent with a medication vial, possibly from a kit.*

FDA Label Image

Figure F (Gattex 11)

An instructional illustration showing a person holding a syringe in one hand and a needle cap in the other, demonstrating the process of removing or attaching the needle cap to the syringe.*

FDA Label Image

Figure G (Gattex 12)

An instructional image showing hands preparing a syringe with a vial of medication, demonstrating the process of drawing liquid from the vial into the syringe, likely related to the use of the Gattex (teduglutide) 5 mg/0.5 mL kit for injection.*

FDA Label Image

Figure H (Gattex 13)

An instructional illustration showing a person using a syringe to draw medication from a small vial. The image demonstrates proper technique for preparing an injection dose, relevant to a prescription drug kit.*

FDA Label Image

Figure I (Gattex 14)

Gattex 5 mg/0.5 mL kit vial shown being held between two hands. The vial is small and labeled, indicating the prescription drug teduglutide by Takeda Pharmaceuticals America, Inc.*

FDA Label Image

Figure J (Gattex 15)

An instructional black-and-white photograph showing hands holding a syringe and a roll of adhesive tape, demonstrating a step in preparing or handling the Gattex (teduglutide) 5 mg/.5 mL kit medication. The image likely illustrates a part of the drug administration or preparation process.*

FDA Label Image

Figure K (Gattex 16)

An instructional photograph showing two hands holding syringe components, likely demonstrating assembly or injection steps related to the Gattex (teduglutide) 5 mg/0.5 mL kit by Takeda Pharmaceuticals America, Inc.*

FDA Label Image

Figure L (Gattex 17)

Illustration showing hands preparing a syringe by drawing medication from a vial, indicating an injection preparation process likely related to the Gattex (teduglutide) 5 mg/0.5 mL kit by Takeda Pharmaceuticals America, Inc.*

FDA Label Image

Figure M (Gattex 18)

An instructional illustration showing hands preparing a syringe by attaching or removing a vial from the syringe barrel, likely related to the administration of Gattex (teduglutide) 5 mg/.5 mL kit by Takeda Pharmaceuticals America, Inc.*

FDA Label Image

Figure N (Gattex 19)

An instructional photo showing a person holding a syringe and vial, preparing to draw medication. The image likely demonstrates proper technique for using the Gattex (teduglutide) 5 mg/0.5 mL kit, a human prescription drug by Takeda Pharmaceuticals America, Inc.*

FDA Label Image

Figure O (Gattex 20)

Black and white illustration showing hands preparing a syringe by drawing liquid from a vial. The image likely demonstrates part of the medication preparation process for an injectable drug kit.*

FDA Label Image

Figure P (Gattex 21)

An instructional illustration showing a person holding a vial labeled Gattex and a syringe prepared for drawing the medication. The image demonstrates the process of withdrawing teduglutide solution from the vial into the syringe for injection.*

FDA Label Image

Figure Q (Gattex 22)

An anatomical illustration showing the abdominal area of a person with demarcated lines forming a rectangular injection site in the lower abdomen, likely indicating where to administer the medication Gattex (teduglutide).*

FDA Label Image

Figure R (Gattex 23)

An illustration showing four positions, each focused on the upper thigh area. The white outlined rectangles indicate specific injection sites on the anterior and lateral parts of the thigh, demonstrating appropriate locations for subcutaneous administration of the drug.*

FDA Label Image

Figure S (Gattex 24)

A black and white instructional image showing a person pinching the skin on their abdomen near the waistline, likely demonstrating a technique related to subcutaneous injection or medication administration.*

FDA Label Image

Figure T (Gattex 25)

An illustration showing a person preparing to inject medication into the lower abdominal area, likely demonstrating the proper injection technique for a subcutaneous injection, consistent with the use of a drug administration kit like Gattex (teduglutide).*

FDA Label Image

Figure U (Gattex 26)

A black-and-white instructional illustration showing hands preparing a subcutaneous injection by holding a syringe near the abdomen area of a person. The image emphasizes the technique for injection administration.*

FDA Label Image

Figure V (Gattex 27)

Packaging label for Gattex 5 mg injection kit containing teduglutide. The label indicates the product is for subcutaneous use only and comes from Takeda Pharmaceuticals America, Inc. The carton includes thirty single-dose vials of Gattex, along with a package insert and medication guide. The Shire logo is also present on the label.*

FDA Label Image

Principal Display Panel (30 Vial Carton)

Packaging label for Gattex 5 mg (teduglutide) injection kit by Takeda Pharmaceuticals America, Inc., labeled for subcutaneous use. The label includes dosage strength, product name, manufacturer details, storage instructions, and a pharmacy use area. The branding includes the Shire logo and a barcode.*

FDA Label Image

Principal Display Panel (30 Vial Kit Carton)

Packaging label for Gattex 5 mg injection kit (teduglutide) by Takeda Pharmaceuticals America, Inc. The label features the Gattex logo with the strength 5 mg indicated. The bottom panel photo shows the kit contents, including multiple vials of teduglutide solution, needles, plastic dosing syringes, alcohol swab pads, and diluent syringes, all organized in the kit box.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.